| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO | Jan 06, 2026 | Gift | - | 2,500 | - | 474,368 | Jan 08, 2026, 06:45 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO | Jan 05, 2026 | Sale | $63.11 | 49,493 | 3,123,349 | 520,033 | Jan 05, 2026, 09:50 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO | Dec 31, 2025 | Gift | - | 2,800 | - | 526,641 | Jan 05, 2026, 09:50 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 06, 2025 | Sale | $19.82 | 29,184 | 578,539 | 544,727 | Jan 07, 2025, 09:28 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 07, 2025 | Sale | $19.69 | 8,000 | 157,520 | 527,201 | Jan 07, 2025, 09:28 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 04, 2024 | Sale | $32.63 | 1,600 | 52,208 | 402,226 | Jan 05, 2024, 07:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 05, 2024 | Sale | $35.27 | 22,841 | 805,716 | 485,326 | Jan 05, 2024, 07:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 03, 2024 | Sale | $32.28 | 8,749 | 282,439 | 408,726 | Jan 05, 2024, 07:58 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 05, 2023 | Sale | $37.39 | 15,000 | 560,850 | 420,875 | Jan 06, 2023, 07:30 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | COO and General Counsel | Jan 03, 2023 | Sale | $38.33 | 17,500 | 670,802 | 378,222 | Jan 05, 2023, 07:10 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Dec 21, 2022 | Option/RSU Exercise | $6.15 | 32,000 | 196,800 | 380,875 | Dec 22, 2022, 08:01 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Dec 04, 2020 | Gift | - | 800 | - | 348,075 | Jan 07, 2022, 08:16 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Jan 05, 2022 | Sale | $61.72 | 32,500 | 2,005,875 | 368,941 | Jan 07, 2022, 08:16 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Dec 31, 2021 | Option/RSU Exercise | $6.15 | 28,000 | 172,200 | 321,375 | Jan 04, 2022, 09:26 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Feb 08, 2021 | Option/RSU Exercise | $5.22 | 90,000 | 469,800 | 383,375 | Feb 10, 2021, 05:56 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Feb 08, 2021 | Sale | $88.46 | 90,000 | 7,961,240 | 375,414 | Feb 10, 2021, 05:56 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Jan 06, 2021 | Sale | $72.41 | 25,000 | 1,810,346 | 317,233 | Jan 07, 2021, 06:11 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Jan 06, 2020 | Sale | $60.12 | 14,625 | 879,261 | 267,406 | Jan 08, 2020, 06:33 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | May 28, 2019 | Sale | $24.88 | 30,000 | 746,400 | 203,000 | May 29, 2019, 07:01 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Patrick O'Brien | General Counsel | Jan 18, 2019 | Sale | $14.43 | 72,000 | 1,038,960 | 233,000 | Jan 18, 2019, 07:02 PM |
- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More